About Prasad

---

Dr. Prasad Panzade
Fractional Chief Technology Officer (CTO)
The Proper Group Executive

Dr. Prasad Panzade is a pharmaceutical R&D strategist, quality systems architect, and regulatory leader with more than 25 years of global experience helping organizations bring therapies from concept to clinic with speed, rigor, and compliance.

As a Fractional Chief Technology Officer, Prasad partners with startups, scale-ups, and established life sciences companies spanning small molecules, biologics, oligonucleotides, peptides, and cell & gene therapies to design right-first-time CMC frameworks, strengthen inspection readiness, and scale global R&D operations.

Prasad’s career includes leading multi-site organizations of 250+ scientists across North America, Europe, and India; authoring and reviewing regulatory submissions and peer-reviewed publications; and driving Lean Six Sigma initiatives that have saved companies more than $7.5M annually. His leadership track record spans executive roles at Nitto Avecia, Catalent, ProtaGene, Apotex, Aditya Birla, Cambrex, Caliper Life Sciences, and more, where he built inspection ready systems, participated and guided FDA/EMA/Health Canada audits, and delivered advanced therapies to patients faster.

Known for his ability to bridge scientific innovation with operational discipline and regulatory precision, Prasad excels in high-stakes environments, whether modernizing labs with ELN/LIMS, EAP platforms, leading cross-functional CMC submissions, or scaling infrastructure for novel modalities. His approach combines technical depth with cultural leadership, fostering collaboration, continuous improvement, and right-first-time execution.

At The Proper Group, Prasad leads fractional CTO engagements, supports organizations in inspection readiness and advanced therapy development, and contributes to the firm’s intellectual property in CMC strategy, continuous improvement, and regulatory frameworks helping clients future proof their R&D and quality systems.

Prasad is based in Toronto, Canada, and serves clients globally. Beyond his executive work, he is passionate about mentoring scientific leaders, advancing operational excellence in biopharma, and ensuring innovation translates into therapies that improve lives.

R&D & CMC Strategy

• End-to-end CMC frameworks and stage gate processes that align science, operations, and regulatory goals
• IND, NDA, ANDA, BLA, and IMPD submission strategy and authorship
• Integration of emerging modalities (small molecules,oligonucleotides, peptides, biologics, cell & gene therapies) into scalable development pathways
• Right-first-time development practices that reduce risk and accelerate timelines
  

Quality Systems & Regulatory Readiness

• Global inspection readiness (FDA, EMA, Health Canada, MHRA, ANVISA, PMDA)
• GxP, ICH, and compliance systems design and implementation
• Analytical quality-by-design (AQbD) and Six Sigma driven improvements
• Continuous improvement playbooks that enhance compliance and minimize deviations
  

Global Operations & Leadership

• Leading 250+ scientists across multi-site organizations in North America, Europe, and India
• Building scalable labs, platforms, and automation systems (ELN, LIMS,EAS,CMMS,CCMS)
• Multi-million-dollar P&L management and strategic growth planning
• Workforce development, training, and mentoring of scientific leadership teams
  

Advanced Modalities Development

• Analytical development and lifecycle management for small molecules,oligonucleotides, peptides, biologics, and advanced therapies
• Inspection ready infrastructure and systems for cell & gene therapy labs
• Technology transfer and method validation/qualification across global sites
• Platform modernization for novel therapies from discovery through commercialization
  

Fractional Executive Leadership

• Fractional CTO engagements (strategic, tactical and technical execution)
• Interim leadership for R&D, quality, or CMC functions during transitions or turnarounds
• Cross functional alignment with operations, regulatory, QA, and executive leadership
• Coaching for scientific, technical and operational leaders to embed compliance and innovation cultures

📍 Based in Toronto, Canada – serving clients globally
🗓 Book a complimentary consultation
📧 ppanzade@theproper.group